Tumour suppressor pulls double shift as reprogramming watchdog

A collaborative study by researchers at the Salk Institute for Biological Studies uncovered that the tumour suppressor p53, which made its name as 'guardian of the genome,' not only stops cells that could become cancerous in their tracks but also controls somatic cell reprogramming...

Read the whole article on

More from